Roivant Sciences (ROIV) Cost of Revenue: 2020-2025
Historic Cost of Revenue for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $111,000.
- Roivant Sciences' Cost of Revenue fell 52.56% to $111,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $758,000, marking a year-over-year decrease of 12.57%. This contributed to the annual value of $911,000 for FY2025, which is 43.03% down from last year.
- Per Roivant Sciences' latest filing, its Cost of Revenue stood at $111,000 for Q3 2025, which was down 27.92% from $154,000 recorded in Q2 2025.
- In the past 5 years, Roivant Sciences' Cost of Revenue ranged from a high of $6.4 million in Q3 2021 and a low of $111,000 during Q3 2025.
- Its 3-year average for Cost of Revenue is $700,625, with a median of $218,000 in 2023.
- Its Cost of Revenue has fluctuated over the past 5 years, first soared by 792.45% in 2021, then plummeted by 94.95% in 2024.
- Roivant Sciences' Cost of Revenue (Quarterly) stood at $1.4 million in 2021, then spiked by 159.10% to $3.6 million in 2022, then plummeted by 94.51% to $197,000 in 2023, then surged by 31.47% to $259,000 in 2024, then slumped by 52.56% to $111,000 in 2025.
- Its Cost of Revenue was $111,000 in Q3 2025, compared to $154,000 in Q2 2025 and $259,000 in Q4 2024.